Eden Research (LON:EDEN) Stock Price Down 13.2% – Time to Sell?

Eden Research plc (LON:EDEN)’s stock price was down 13.2% during mid-day trading on Tuesday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares were traded during trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Down 1.9 %

The stock has a market capitalization of £13.87 million, a P/E ratio of -9.11 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a fifty day moving average price of GBX 3.34 and a 200 day moving average price of GBX 3.70.

Insiders Place Their Bets

In other Eden Research news, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction that occurred on Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,296.97). Also, insider Alexander John Abrey bought 167,947 shares of the firm’s stock in a transaction on Tuesday, March 4th. The stock was acquired at an average price of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,542.54). Insiders purchased a total of 1,391,473 shares of company stock worth $103,604,725 in the last quarter. 14.02% of the stock is owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.